-
Mashup Score: 41
Deepak Bhatt, MD, MPH, MBA, spoke to Cardiovascular Business about the growing importance of evaluating coronary inflammation in heart patients. There has been an explosion of interest in this area since the FDA’s 2023 clearance of colchicine.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 41
Deepak Bhatt, MD, MPH, MBA, spoke to Cardiovascular Business about the growing importance of evaluating coronary inflammation in heart patients. There has been an explosion of interest in this area since the FDA’s 2023 clearance of colchicine.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Cardiologist examines the latest breakthroughs in coronary inflammation research https://t.co/GHk7IeG7wx
-
-
Mashup Score: 41
Deepak Bhatt, MD, MPH, MBA, spoke to Cardiovascular Business about the growing importance of evaluating coronary inflammation in heart patients. There has been an explosion of interest in this area since the FDA’s 2023 clearance of colchicine.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Cardiologist examines the latest breakthroughs in coronary inflammation research https://t.co/GHk7IeG7wx
-
-
Mashup Score: 82New Blood Pressure Target For Individuals at High Risk - American College of Cardiology - 6 month(s) ago
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in Reducing Risk of Vascular Events) trial was the largest randomized controlled trial investigating the CV outcomes of targeting systolic blood pressure (SBP) to < 120 mm Hg in individuals regardless of history of diabetes mellitus or stroke. Targeting SBP to < 120 mm Hg decreases CV events in individuals at
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
New Blood Pressure Target For Individuals at High Risk - American College of Cardiology https://t.co/O0liBiCspN ESPRIT + SPRINT support more agressive ⬇️BP for individuals at risk for CVD or with underlying coronary atherosclerosis. Excellent summary by @rblument1 et al
-
-
Mashup Score: 82New Blood Pressure Target For Individuals at High Risk - American College of Cardiology - 6 month(s) ago
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in Reducing Risk of Vascular Events) trial was the largest randomized controlled trial investigating the CV outcomes of targeting systolic blood pressure (SBP) to < 120 mm Hg in individuals regardless of history of diabetes mellitus or stroke. Targeting SBP to < 120 mm Hg decreases CV events in individuals at
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
New Blood Pressure Target For Individuals at High Risk - American College of Cardiology https://t.co/O0liBiCspN ESPRIT + SPRINT support more agressive ⬇️BP for individuals at risk for CVD or with underlying coronary atherosclerosis. Excellent summary by @rblument1 et al
-
-
Mashup Score: 79New Blood Pressure Target For Individuals at High Risk - American College of Cardiology - 6 month(s) ago
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in Reducing Risk of Vascular Events) trial was the largest randomized controlled trial investigating the CV outcomes of targeting systolic blood pressure (SBP) to < 120 mm Hg in individuals regardless of history of diabetes mellitus or stroke. Targeting SBP to < 120 mm Hg decreases CV events in individuals at
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
New Blood Pressure Target For Individuals at High Risk - American College of Cardiology https://t.co/O0liBiCspN ESPRIT + SPRINT support more agressive ⬇️BP for individuals at risk for CVD or with underlying coronary atherosclerosis. Excellent summary by @rblument1 et al
-
-
Mashup Score: 79New Blood Pressure Target For Individuals at High Risk - American College of Cardiology - 6 month(s) ago
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in Reducing Risk of Vascular Events) trial was the largest randomized controlled trial investigating the CV outcomes of targeting systolic blood pressure (SBP) to < 120 mm Hg in individuals regardless of history of diabetes mellitus or stroke. Targeting SBP to < 120 mm Hg decreases CV events in individuals at
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
New Blood Pressure Target For Individuals at High Risk - American College of Cardiology https://t.co/O0liBiCspN ESPRIT + SPRINT support more agressive ⬇️BP for individuals at risk for CVD or with underlying coronary atherosclerosis. Excellent summary by @rblument1 et al
-
-
Mashup Score: 19U.S. CMS agrees to double reimbursement for cardiovascular CT services - Society of Cardiovascular Computed Tomography - 6 month(s) ago
This web site uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more. Accept Deny The U.S. Centers for Medicare and Medicaid Services (CMS) approved a reclassification of coronary
Source: scct.orgCategories: General Medicine News, CardiologistsTweet-
RT @Heart_SCCT: Huge news for the #YesCCT community! Learn more at https://t.co/ZjSbzCzsu6 @RonBlankstein @lesleejshaw @Ahmad_M_Slim @Kan…
-
-
Mashup Score: 17U.S. CMS agrees to double reimbursement for cardiovascular CT services - Society of Cardiovascular Computed Tomography - 6 month(s) ago
This web site uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more. Accept Deny The U.S. Centers for Medicare and Medicaid Services (CMS) approved a reclassification of coronary
Source: scct.orgCategories: General Medicine News, CardiologistsTweet-
RT @Heart_SCCT: Huge news for the #YesCCT community! Learn more at https://t.co/ZjSbzCzsu6 @RonBlankstein @lesleejshaw @Ahmad_M_Slim @Kan…
-
-
Mashup Score: 50SCCT Prevention Symposium - 6 month(s) ago
This website uses cookies to store information on your computer. Some of these cookies are us ed for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more. Accept Deny Nikki Weber, R.T.(R)(CT)(M)(ARRT),
Source: scct.orgCategories: General Medicine News, CardiologistsTweet-
Join us tomorrow 11/2 @ 10am EST for a great line up of speakers covering all the latest topics in preventive cardiology #PreventionIsTheIntervention ▶️https://t.co/XCGg0zo7U7 https://t.co/itQNW57j4L
-
Cardiologist examines the latest breakthroughs in coronary inflammation research https://t.co/GHk7IeG7wx